Ildong Pharmaceutical Revenue

Ildong Pharmaceutical had revenue of 138.48B KRW in the quarter ending June 30, 2025, a decrease of -8.98%. This brings the company's revenue in the last twelve months to 586.15B, down -2.93% year-over-year. In the year 2024, Ildong Pharmaceutical had annual revenue of 614.94B with 2.36% growth.

Revenue (ttm)

586.15B

Revenue Growth

-2.93%

P/S Ratio

1.53

Revenue / Employee

549.34M

Employees

1,067

Market Cap

894.83B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	614.94B	14.18B	2.36%
Dec 31, 2023	600.76B	-36.96B	-5.80%
Dec 31, 2022	637.71B	77.58B	13.85%
Dec 31, 2021	560.13B	-1.71B	-0.30%
Dec 31, 2020	561.85B	44.38B	8.58%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	5.03T
Celltrion	3.75T
Yuhan	2.17T
SK Biopharmaceuticals	620.28B
PharmaResearch	449.81B
Sam Chun Dang Pharm.	215.10B
ALTEOGEN	158.06B
LigaChem Biosciences	148.28B

Revenue Rankings